HK1145284A1 - A slow-release formulation based on an association of glycogen and alginate - Google Patents

A slow-release formulation based on an association of glycogen and alginate

Info

Publication number
HK1145284A1
HK1145284A1 HK10111374.1A HK10111374A HK1145284A1 HK 1145284 A1 HK1145284 A1 HK 1145284A1 HK 10111374 A HK10111374 A HK 10111374A HK 1145284 A1 HK1145284 A1 HK 1145284A1
Authority
HK
Hong Kong
Prior art keywords
glycogen
alginate
association
slow
release formulation
Prior art date
Application number
HK10111374.1A
Other languages
English (en)
Inventor
Vincenzo Russo
Elisa Liberati
Nicola Cazzolla
Leonardo Marchitto
Lorella Ragni
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1145284A1 publication Critical patent/HK1145284A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK10111374.1A 2007-12-28 2010-12-07 A slow-release formulation based on an association of glycogen and alginate HK1145284A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07425828 2007-12-28
PCT/EP2008/068256 WO2009083561A1 (en) 2007-12-28 2008-12-23 A slow-release formulation based on an association of glycogen and alginate

Publications (1)

Publication Number Publication Date
HK1145284A1 true HK1145284A1 (en) 2011-04-15

Family

ID=39522216

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10111374.1A HK1145284A1 (en) 2007-12-28 2010-12-07 A slow-release formulation based on an association of glycogen and alginate

Country Status (21)

Country Link
US (1) US8840923B2 (pl)
EP (1) EP2234607B1 (pl)
JP (1) JP5416716B2 (pl)
KR (1) KR101561571B1 (pl)
CN (1) CN101909608B (pl)
AR (1) AR069960A1 (pl)
AT (1) ATE518530T1 (pl)
AU (1) AU2008342571B2 (pl)
BR (1) BRPI0821454B8 (pl)
CA (1) CA2708400C (pl)
DK (1) DK2234607T3 (pl)
EA (1) EA018975B1 (pl)
ES (1) ES2369868T3 (pl)
GE (1) GEP20125636B (pl)
HK (1) HK1145284A1 (pl)
IL (1) IL206124A (pl)
PL (1) PL2234607T3 (pl)
PT (1) PT2234607E (pl)
SI (1) SI2234607T1 (pl)
UA (1) UA98684C2 (pl)
WO (1) WO2009083561A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101713810B1 (ko) 2009-01-23 2017-03-09 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 제어 방출형 약학적 제제 또는 식품 제제 및 이의 제조 방법
HUE027721T2 (en) * 2009-08-03 2016-10-28 Acraf Food preparation containing glycogen
CA2910399C (en) 2013-04-26 2021-05-18 Mirexus Biotechnologies Inc. Phytoglycogen nanoparticles and methods of manufacture thereof
CN106137977B (zh) * 2015-04-28 2019-12-13 浙江普利药业有限公司 海参多糖肠溶微丸及其制备方法
ITUB20152290A1 (it) * 2015-07-17 2017-01-17 Laboratori Baldacci Spa Prodotto a base di ferro bisglicinato chelato e acido alginico e/o suoi sali idrosolubili, sue formulazioni ed suoi usi farmaceutici
US11865099B2 (en) 2015-07-17 2024-01-09 Laboratori Baldacci S.P.A. Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
US20190038542A1 (en) * 2016-02-08 2019-02-07 Mirexus Biotechnologies Inc. Moisturizing personal care compositions comprising monodisperse phytoglycogen nanoparticles and a further polysaccharide

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
DE2062715C3 (de) 1970-12-19 1974-03-21 Efeka Friedrich & Kaufmann Arzneimittelfabrik, 3000 Hannover Verfahren zur Herstellung von oral applizierbaren Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe und Arzneimittelzubereitung
DE3583799D1 (de) 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
JPS62178505A (ja) 1986-02-03 1987-08-05 Maruzen Kasei Kk 化粧料
JPS63290809A (ja) 1987-05-25 1988-11-28 Noebia:Kk 口唇用化粧料
CA2041774C (en) 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US5705190A (en) 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5807575A (en) 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
IT1298758B1 (it) 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
AU2001227030A1 (en) * 2000-11-22 2002-06-03 Lupin Laboratories Limited Pharmaceutical composition for controlled release of an active ingredient
CA2638788A1 (en) * 2003-04-25 2004-11-11 Kos Life Sciences, Inc. Formation of strong superporous hydrogels
US20060067917A1 (en) 2004-09-20 2006-03-30 Athanassios Sambanis Insulin delivery system
US7687608B2 (en) 2005-10-19 2010-03-30 Smartcells, Inc. Methods for reducing the mitogenicity of lectin compositions

Also Published As

Publication number Publication date
EA201070806A1 (ru) 2010-12-30
AU2008342571A1 (en) 2009-07-09
BRPI0821454B8 (pt) 2021-05-25
ES2369868T3 (es) 2011-12-07
US20100255083A1 (en) 2010-10-07
WO2009083561A1 (en) 2009-07-09
AR069960A1 (es) 2010-03-03
CN101909608A (zh) 2010-12-08
BRPI0821454A2 (pt) 2015-06-16
CA2708400C (en) 2016-02-02
UA98684C2 (uk) 2012-06-11
JP5416716B2 (ja) 2014-02-12
CN101909608B (zh) 2013-01-23
AU2008342571B2 (en) 2014-03-13
KR20100099728A (ko) 2010-09-13
BRPI0821454B1 (pt) 2020-01-28
DK2234607T3 (da) 2011-11-21
EP2234607B1 (en) 2011-08-03
CA2708400A1 (en) 2009-07-09
PL2234607T3 (pl) 2011-12-30
GEP20125636B (en) 2012-09-10
KR101561571B1 (ko) 2015-10-19
ATE518530T1 (de) 2011-08-15
US8840923B2 (en) 2014-09-23
SI2234607T1 (sl) 2011-11-30
EA018975B1 (ru) 2013-12-30
IL206124A (en) 2013-01-31
IL206124A0 (en) 2010-11-30
EP2234607A1 (en) 2010-10-06
PT2234607E (pt) 2011-09-30
JP2011519820A (ja) 2011-07-14

Similar Documents

Publication Publication Date Title
HK1145284A1 (en) A slow-release formulation based on an association of glycogen and alginate
EP2043952A4 (en) MIXTURES OF FULLERENE DERIVATIVES AND THEIR USES IN ELECTRONIC DEVICES
GB2492703B (en) Bootstrapper and software download manager
GB2450669B (en) Tantalam powder and methods of manufacturing same
IL198146A0 (en) Compositions and devices comprising silicone and specific polyphosphazenes
IL194733A0 (en) Photodisinfection delivery devices and methods
HK1131094A1 (en) Nanoparticles, methods of making, and applications using same
EP2177557A4 (en) LASER FRITTABLE POWDER AND SHAPED PRODUCT THEREOF
EP2054063A4 (en) 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
ZA200903876B (en) Dental attachment assemly and method
EP2006284A4 (en) DICYCLOOCTANE DERIVATIVES, METHOD OF MANUFACTURE AND MEDICAL APPLICATIONS THEREOF
AP2008004629A0 (en) Pseudoinfectious flavivirus and uses thereof
IL194751A0 (en) Drugs and uses
HK1132974A1 (en) Transport unit and method of manufacture thereof
EP1997777A4 (en) SILICON DIOXIDE POWDER AND ITS USE
ZA200905170B (en) Artificial teethridge and fang
EP2318001A4 (en) FORMULATION WITH MODIFIED RELEASE AND USE METHOD
ZA200705774B (en) Osteotome and components thereof
WO2009091274A9 (en) Appliance and procedure designed for the improvement of plant-production in the specially protected environment
TWI369233B (en) Game system and server
GB0613288D0 (en) Preservation and controlled delivery/release of spermatoza
GB0709812D0 (en) Calibration method and calibration manager
HK1136303A1 (en) Formulation and use of ergosta-7,22-dien-3-ol -722--3-
IL192552A0 (en) Dnt-succinate and methods of preparation thereof
ZA200902942B (en) Combination of IAP Inhibitors and FLT3 Inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201223